MedPath

Study of Diagnostic Biomarkers of Acute Acoustic Trauma

Recruiting
Conditions
Acoustic Trauma
Interventions
Other: Hearing test
Other: Questionnaire about previous noise exposure
Other: Otoacoustic emission measurement
Other: Electrocochleography
Other: Speech audiometry in noise
Other: Multi-frequency impedance measurement
Other: Assessment of tinnitus severity
Biological: Blood sample collection
Registration Number
NCT04832230
Lead Sponsor
Direction Centrale du Service de Santé des Armées
Brief Summary

Every year, more than two thousand acute acoustic trauma occur in France, equally between the military and the civilian environment.

Currently, acute acoustic trauma is a pathology with no specific validated treatment, and it is the cause of many handicapping situations. Improving the future of patients requires a better understanding of the neurophysiological mechanisms of noise-induced hearing impairment. They are multiple and pure tone audiometry, the only reference examination, does not allow to differentiate them. Moreover, in the aftermath of acute acoustic trauma, pure tone audiometry tends to improve spontaneously, but this recovery is misleading, as a number of studies in animals have shown that irreversible lesions remain.

The hypothesis of this study is that it is possible to identify new entities, specific to the type of cochlear lesions, in order to clarify the diagnosis of acute acoustic trauma. These entities will be identified by the evaluation of noise-induced hearing impairment via a combination of molecular (proteomic and genomic), physiological and behavioral data. These diagnostic details may then be used to improve prevention or therapy.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
500
Inclusion Criteria
  • Age between 18 and 40
  • Healthy individuals: without hearing pathology
  • Patients: acute acoustic trauma diagnosis within 72h
Exclusion Criteria
  • History of hearing pathology
  • History of severe head injury
  • Ototoxic drug therapy
  • Abnormal otoscopy and/or tympanometry

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Healthy individualsOtoacoustic emission measurementThis group is composed of healthy individuals without previous noise exposure.
Acute acoustic trauma patientsElectrocochleographyThis group is composed of patients suffering from acute acoustic trauma.
Acute acoustic trauma patientsMulti-frequency impedance measurementThis group is composed of patients suffering from acute acoustic trauma.
Acute acoustic trauma patientsHearing testThis group is composed of patients suffering from acute acoustic trauma.
Acute acoustic trauma patientsBlood sample collectionThis group is composed of patients suffering from acute acoustic trauma.
Healthy individualsMulti-frequency impedance measurementThis group is composed of healthy individuals without previous noise exposure.
Acute acoustic trauma patientsQuestionnaire about previous noise exposureThis group is composed of patients suffering from acute acoustic trauma.
Acute acoustic trauma patientsOtoacoustic emission measurementThis group is composed of patients suffering from acute acoustic trauma.
Healthy individualsQuestionnaire about previous noise exposureThis group is composed of healthy individuals without previous noise exposure.
Healthy individualsHearing testThis group is composed of healthy individuals without previous noise exposure.
Healthy individualsElectrocochleographyThis group is composed of healthy individuals without previous noise exposure.
Healthy individualsSpeech audiometry in noiseThis group is composed of healthy individuals without previous noise exposure.
Healthy individualsBlood sample collectionThis group is composed of healthy individuals without previous noise exposure.
Acute acoustic trauma patientsSpeech audiometry in noiseThis group is composed of patients suffering from acute acoustic trauma.
Acute acoustic trauma patientsAssessment of tinnitus severityThis group is composed of patients suffering from acute acoustic trauma.
Primary Outcome Measures
NameTimeMethod
Identification of diagnostic biomarkers of hearing impairment in patients suffering from acute acoustic traumaThrough study completion, an average of 3 years

Machine learning analyses will be performed on the whole collected data to identify diagnostic biomarkers.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (14)

38e Antenne Médicale

🇫🇷

Bitche, France

Laboratoire mobile d'Audition de l'Institut de Recherche Biomédicale des Armées

🇫🇷

Brétigny-sur-Orge, France

171e Antenne Médicale

🇫🇷

Caylus, France

41e Antenne Médicale

🇫🇷

Dieuze, France

13e Antenne Médicale

🇫🇷

Montlhéry, France

123e Antenne Médicale

🇫🇷

Guer, France

60e Antenne Médicale

🇫🇷

Valdahon, France

Hôpital d'Instruction des Armées Sainte-Anne

🇫🇷

Toulon, France

102e Antenne Médicale

🇫🇷

Angoulême, France

109e Antenne Médicale

🇫🇷

Saint-Maixent-l'École, France

Hôpital d'Instruction des Armées Clermont-Tonnerre

🇫🇷

Brest, France

Hôpital d'Instruction des Armées Percy

🇫🇷

Clamart, France

Hôpital d'Instruction des Armées Laveran

🇫🇷

Marseille, France

43e Antenne Médicale

🇫🇷

Sarrebourg, France

© Copyright 2025. All Rights Reserved by MedPath